Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Still Bullish After All These Years

Q: Which biotechs look good now?

A: I think on a long-term basis both Amgen (AMGN ) and Genentech (DNA ) can be included in a portfolio, despite the fact that the valuations are relatively high. Johnson & Johnson (JNJ ) continues to impress me as a company transitioning to higher market products, not just in biotech but also in devices. Clearly, the scientific component of their product portfolio is getting stronger. It won't surprise me if the stock hits a new high today.

blog comments powered by Disqus